Rabusa, Remelyn L.

HRN: 19-22-70  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/19/2022
CEFUROXIME 1.5GM (VIAL)
08/20/2022
08/20/2022
IVT
1.5g
LD
Preop Prophylaxis
Waiting Final Action 
08/20/2022
CEFUROXIME 1.5GM (VIAL)
08/20/2022
08/21/2022
IVT
1.5gm
Q8 X 2 More Doses
Post-op TAHBSO
Waiting Final Action 
08/21/2022
CEFUROXIME 500MG (TAB)
08/21/2022
08/28/2022
ORAL
500mg
Q12
UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: